Fig. 1From: Healthcare utilization and cost of cancer-related care prior to allogeneic hematopoietic cell transplantation for hematologic malignancies in the US: a retrospective real-world analysisHypothetical patient flow. Full study period (1/1/2004–12/31/2017) and analysis dates and time periods for a hypothetical patient who had HCT on January 1, 2011Back to article page